Reshaping the landscape of drug discovery with AI-Powered BCP

Our mission at Linnaeus Bioscience is dedicated to accelerating the antimicrobial discovery process and arming the global community in its battle against antibiotic resistant bacteria. Founded in 2012 based upon discoveries from the Pogliano Lab at the University of California, San Diego, Linnaeus Bioscience has developed bacterial cytological profiling (BCP) supported by in-house machine learning into a robust tool to enable new therapeutic breakthroughs.

slide specimen being placed on a microscope
Scientist looking in to microscope

More than a bioscience company

We are a solutions-oriented partner. Our involvement in diverse discovery and development projects underlines our wide range of expertise and our commitment to meet the unique and complex needs of our clients.

Our Team

Profile image for Joe Pogliano

JOE POGLIANO

Founder

Profile image of Kit Pogliano

KIT POGLIANO

Founder

Profile image of Marc Sharp

MARC D. SHARP

Chief Scientific Officer

Profile imge of Hannah Tsunemoto

HANNAH TSUNEMOTO

Chief Operations Officer

Profile image of Diana Quach

DIANA QUACH

Lead Scientist

Profile image for Joe Sugie

JOE SUGIE

Chief Technology Officer

Scientific Advisory Board

Profile image of Karen Joy Shaw

KAREN JOY SHAW

Profile image of Lynn Silver

LYNN L. SILVER

Profile image of MICHAEL BARBACHYN

MICHAEL BARBACHYN

Profile image of FREDERIK DEROOSE

FREDERIK DEROOSE